The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Psoriatic Arthritis Drugs-Global Market Insights and Sales Trends 2025
Synopsis
The global Psoriatic Arthritis Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Psoriatic Arthritis Drugs in various end use industries. The expanding demands from the Mild Psoriatic Arthritis, Moderate Psoriatic Arthritis and Severe Psoriatic Arthritis,, are propelling Psoriatic Arthritis Drugs market. TNF Inhibitors, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the PDE4 Inhibitors segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Psoriatic Arthritis Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Psoriatic Arthritis Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Psoriatic Arthritis Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Psoriatic Arthritis Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Psoriatic Arthritis Drugs covered in this report include Abbvie, Janssen, Amgen, Pfizer, Eli-Lilly and Celgene, etc.
The global Psoriatic Arthritis Drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbvie
Janssen
Amgen
Pfizer
Eli-Lilly
Celgene
Global Psoriatic Arthritis Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Psoriatic Arthritis Drugs market, Segment by Type:
TNF Inhibitors
PDE4 Inhibitors
Interleukin Blockers
Other
Global Psoriatic Arthritis Drugs market, by Application
Mild Psoriatic Arthritis
Moderate Psoriatic Arthritis
Severe Psoriatic Arthritis
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Psoriatic Arthritis Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Psoriatic Arthritis Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
The global Psoriatic Arthritis Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Psoriatic Arthritis Drugs in various end use industries. The expanding demands from the Mild Psoriatic Arthritis, Moderate Psoriatic Arthritis and Severe Psoriatic Arthritis,, are propelling Psoriatic Arthritis Drugs market. TNF Inhibitors, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the PDE4 Inhibitors segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Psoriatic Arthritis Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Psoriatic Arthritis Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Psoriatic Arthritis Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Psoriatic Arthritis Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Psoriatic Arthritis Drugs covered in this report include Abbvie, Janssen, Amgen, Pfizer, Eli-Lilly and Celgene, etc.
The global Psoriatic Arthritis Drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbvie
Janssen
Amgen
Pfizer
Eli-Lilly
Celgene
Global Psoriatic Arthritis Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Psoriatic Arthritis Drugs market, Segment by Type:
TNF Inhibitors
PDE4 Inhibitors
Interleukin Blockers
Other
Global Psoriatic Arthritis Drugs market, by Application
Mild Psoriatic Arthritis
Moderate Psoriatic Arthritis
Severe Psoriatic Arthritis
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Psoriatic Arthritis Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Psoriatic Arthritis Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Psoriatic Arthritis Drugs Market Overview
1.1 Psoriatic Arthritis Drugs Product Overview
1.2 Psoriatic Arthritis Drugs Market Segment by Type
1.2.1 TNF Inhibitors
1.2.2 PDE4 Inhibitors
1.2.3 Interleukin Blockers
1.2.4 Other
1.3 Global Psoriatic Arthritis Drugs Market Size by Type
1.3.1 Global Psoriatic Arthritis Drugs Market Size Overview by Type (2018-2029)
1.3.2 Global Psoriatic Arthritis Drugs Historic Market Size Review by Type (2018-2023)
1.3.3 Global Psoriatic Arthritis Drugs Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Psoriatic Arthritis Drugs Sales Breakdown by Type (2018-2023)
1.4.2 Europe Psoriatic Arthritis Drugs Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Psoriatic Arthritis Drugs Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Psoriatic Arthritis Drugs Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Psoriatic Arthritis Drugs Sales Breakdown by Type (2018-2023)
2 Global Psoriatic Arthritis Drugs Market Competition by Company
2.1 Global Top Players by Psoriatic Arthritis Drugs Sales (2018-2023)
2.2 Global Top Players by Psoriatic Arthritis Drugs Revenue (2018-2023)
2.3 Global Top Players by Psoriatic Arthritis Drugs Price (2018-2023)
2.4 Global Top Manufacturers Psoriatic Arthritis Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Psoriatic Arthritis Drugs Market Competitive Situation and Trends
2.5.1 Psoriatic Arthritis Drugs Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Psoriatic Arthritis Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Psoriatic Arthritis Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into Psoriatic Arthritis Drugs Market
2.8 Key Manufacturers Psoriatic Arthritis Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Psoriatic Arthritis Drugs Status and Outlook by Region
3.1 Global Psoriatic Arthritis Drugs Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Psoriatic Arthritis Drugs Historic Market Size by Region
3.2.1 Global Psoriatic Arthritis Drugs Sales in Volume by Region (2018-2023)
3.2.2 Global Psoriatic Arthritis Drugs Sales in Value by Region (2018-2023)
3.2.3 Global Psoriatic Arthritis Drugs Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Psoriatic Arthritis Drugs Forecasted Market Size by Region
3.3.1 Global Psoriatic Arthritis Drugs Sales in Volume by Region (2024-2029)
3.3.2 Global Psoriatic Arthritis Drugs Sales in Value by Region (2024-2029)
3.3.3 Global Psoriatic Arthritis Drugs Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Psoriatic Arthritis Drugs by Application
4.1 Psoriatic Arthritis Drugs Market Segment by Application
4.1.1 Mild Psoriatic Arthritis
4.1.2 Moderate Psoriatic Arthritis
4.1.3 Severe Psoriatic Arthritis
4.2 Global Psoriatic Arthritis Drugs Market Size by Application
4.2.1 Global Psoriatic Arthritis Drugs Market Size Overview by Application (2018-2029)
4.2.2 Global Psoriatic Arthritis Drugs Historic Market Size Review by Application (2018-2023)
4.2.3 Global Psoriatic Arthritis Drugs Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Psoriatic Arthritis Drugs Sales Breakdown by Application (2018-2023)
4.3.2 Europe Psoriatic Arthritis Drugs Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Psoriatic Arthritis Drugs Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Psoriatic Arthritis Drugs Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Psoriatic Arthritis Drugs Sales Breakdown by Application (2018-2023)
5 North America Psoriatic Arthritis Drugs by Country
5.1 North America Psoriatic Arthritis Drugs Historic Market Size by Country
5.1.1 North America Psoriatic Arthritis Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Psoriatic Arthritis Drugs Sales in Volume by Country (2018-2023)
5.1.3 North America Psoriatic Arthritis Drugs Sales in Value by Country (2018-2023)
5.2 North America Psoriatic Arthritis Drugs Forecasted Market Size by Country
5.2.1 North America Psoriatic Arthritis Drugs Sales in Volume by Country (2024-2029)
5.2.2 North America Psoriatic Arthritis Drugs Sales in Value by Country (2024-2029)
6 Europe Psoriatic Arthritis Drugs by Country
6.1 Europe Psoriatic Arthritis Drugs Historic Market Size by Country
6.1.1 Europe Psoriatic Arthritis Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Psoriatic Arthritis Drugs Sales in Volume by Country (2018-2023)
6.1.3 Europe Psoriatic Arthritis Drugs Sales in Value by Country (2018-2023)
6.2 Europe Psoriatic Arthritis Drugs Forecasted Market Size by Country
6.2.1 Europe Psoriatic Arthritis Drugs Sales in Volume by Country (2024-2029)
6.2.2 Europe Psoriatic Arthritis Drugs Sales in Value by Country (2024-2029)
7 Asia-Pacific Psoriatic Arthritis Drugs by Region
7.1 Asia-Pacific Psoriatic Arthritis Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Psoriatic Arthritis Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Psoriatic Arthritis Drugs Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Psoriatic Arthritis Drugs Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Psoriatic Arthritis Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Psoriatic Arthritis Drugs Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Psoriatic Arthritis Drugs Sales in Value by Region (2024-2029)
8 Latin America Psoriatic Arthritis Drugs by Country
8.1 Latin America Psoriatic Arthritis Drugs Historic Market Size by Country
8.1.1 Latin America Psoriatic Arthritis Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Psoriatic Arthritis Drugs Sales in Volume by Country (2018-2023)
8.1.3 Latin America Psoriatic Arthritis Drugs Sales in Value by Country (2018-2023)
8.2 Latin America Psoriatic Arthritis Drugs Forecasted Market Size by Country
8.2.1 Latin America Psoriatic Arthritis Drugs Sales in Volume by Country (2024-2029)
8.2.2 Latin America Psoriatic Arthritis Drugs Sales in Value by Country (2024-2029)
9 Middle East and Africa Psoriatic Arthritis Drugs by Country
9.1 Middle East and Africa Psoriatic Arthritis Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Psoriatic Arthritis Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Psoriatic Arthritis Drugs Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Psoriatic Arthritis Drugs Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Psoriatic Arthritis Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Psoriatic Arthritis Drugs Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Psoriatic Arthritis Drugs Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Abbvie
10.1.1 Abbvie Company Information
10.1.2 Abbvie Introduction and Business Overview
10.1.3 Abbvie Psoriatic Arthritis Drugs Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Abbvie Psoriatic Arthritis Drugs Products Offered
10.1.5 Abbvie Recent Development
10.2 Janssen
10.2.1 Janssen Company Information
10.2.2 Janssen Introduction and Business Overview
10.2.3 Janssen Psoriatic Arthritis Drugs Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Janssen Psoriatic Arthritis Drugs Products Offered
10.2.5 Janssen Recent Development
10.3 Amgen
10.3.1 Amgen Company Information
10.3.2 Amgen Introduction and Business Overview
10.3.3 Amgen Psoriatic Arthritis Drugs Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Amgen Psoriatic Arthritis Drugs Products Offered
10.3.5 Amgen Recent Development
10.4 Pfizer
10.4.1 Pfizer Company Information
10.4.2 Pfizer Introduction and Business Overview
10.4.3 Pfizer Psoriatic Arthritis Drugs Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Pfizer Psoriatic Arthritis Drugs Products Offered
10.4.5 Pfizer Recent Development
10.5 Eli-Lilly
10.5.1 Eli-Lilly Company Information
10.5.2 Eli-Lilly Introduction and Business Overview
10.5.3 Eli-Lilly Psoriatic Arthritis Drugs Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Eli-Lilly Psoriatic Arthritis Drugs Products Offered
10.5.5 Eli-Lilly Recent Development
10.6 Celgene
10.6.1 Celgene Company Information
10.6.2 Celgene Introduction and Business Overview
10.6.3 Celgene Psoriatic Arthritis Drugs Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Celgene Psoriatic Arthritis Drugs Products Offered
10.6.5 Celgene Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Psoriatic Arthritis Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Psoriatic Arthritis Drugs Industrial Chain Analysis
11.4 Psoriatic Arthritis Drugs Market Dynamics
11.4.1 Psoriatic Arthritis Drugs Industry Trends
11.4.2 Psoriatic Arthritis Drugs Market Drivers
11.4.3 Psoriatic Arthritis Drugs Market Challenges
11.4.4 Psoriatic Arthritis Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Psoriatic Arthritis Drugs Distributors
12.3 Psoriatic Arthritis Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
